CNN via Yahoo
FDA approves donanemab, Eli Lilly’s treatment for early Alzheimer’s disease
The US Food and Drug Administration on Tuesday approved donanemab, a monoclonal antibody designed to slow the progression of early symptomatic Alzheimer’s disease.
4 days ago